Phase 1 Inflammatory Bowel Diseases Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Children's Hospital Medical Center, Cincinnati116 enrolled3 locationsNCT03847467
Recruiting
Phase 1
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD
Inflammatory Bowel Diseases
The Foundation for Orthopaedics and Regenerative Medicine15 enrolled2 locationsNCT05003947
Recruiting
Phase 1Phase 2
Microbial Restoration in Inflammatory Bowel Diseases
Inflammatory Bowel DiseasesCrohn DiseaseMicrobiome+1 more
St Vincent's Hospital Melbourne120 enrolled1 locationNCT04970446
Recruiting
Phase 1
Phase 1 Study for IPG11406 in Health Volunteer
Inflammatory Bowel Diseases
Nanjing Immunophage Biotech Co., Ltd66 enrolled1 locationNCT06255834
Recruiting
Phase 1Phase 2
Beta-Hydroxybutyrate Feasibility Treating IBD
Inflammatory Bowel DiseasesCrohn's Disease
University of Texas at Austin20 enrolled1 locationNCT06351124